Rol' Meksidola v terapii umerennykh kognitivnykh rasstroystv v ramkakh proyavleniya khronicheskoy nedostatochnosti mozgovogo krovoobrashcheniya


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the results of the evaluation of the etiology of mild cognitive impairment (MCI) in chronic cerebrovascular insufficiency (CCI) and effects Mexidol on the recovery of lost mnemonic functions in 107 patients with MCI aged 53-60 years. It is shown that the application of Mexidol in patients with MCI in CCI led to a reduction of cognitive decline, as well as improvement of overall health of patients, and reduction of the severity of asthenic and neurotic symptoms. These effects confirm the appropriateness of including of Mexidol in the scheme of pathogenetic therapy of MCI.

Full Text

Restricted Access

References

  1. Гаврилова С.И. Мягкое когнитивное снижение - доклиническая стадия болезни Альцгеймера? // Consilium Medicum 2004. № 2. 153-56.
  2. Левин О.С, Голубева Л.В. Когнитивные расстройства: Гетерогенность умеренного когнитивного расстройства: диагностические и терапевтические аспекты // Concilium Medicum 2006. Т. 8. № 2.
  3. Левин О.С. Когнитивные нарушения в практике невролога. М., 2006.
  4. Штульман Д.Р., Левин О.С. Умеренные когнитивные нарушения. Неврология. Справочник практического врача. М., 2005. С. 226-29.
  5. Яхно Н.Н., Захаров В.В. Легкие когнитивные расстройства в пожилом возрасте // Неврологический журнал 2004. Т. 9. № 1. С. 4-8.
  6. Budson AE, Price BH. Memory dysfunction. NEJM 2005;352:692-99.
  7. DiCarlo A, Baldereschi M, Amaducci L, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Ger Soc 2000;48:775-82.
  8. Dubois B, Albert ML. Amnestic MCI or prodromal Alzheimer's disease. Lancet Neurology 2004;3:246-48.
  9. Galluzzi S, Sheu C-F, Zanetti O, et al. Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease. Dement Geriatr Cogn Disord 2005; 19:196-203.
  10. Gauthier S, Touchon J. Subclassification of mild cognitive impairment in research and in clinical practice. Alzheimer's Disease and Related Disorders Annual. 2004:61-70.
  11. Petersen RC, Stevens JC, Ganguli M, et al. Mild cognitive impairment (an evidence-based review). Neurology 2001;56:1131-42.
  12. Petersen RC, Thomas RG, Grudman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. NEJM 2005;352:2379-88.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media